$0.88
-0.02 (-2.01%)
Open$0.88
Previous Close$0.89
Day High$0.90
Day Low$0.85
52W High$9.00
52W Low$0.69
Volume—
Avg Volume556.1K
Market Cap28.17M
P/E Ratio—
EPS$-1.74
SectorBiotechnology
Analyst Ratings
Strong Sell
6 analysts
Price Target
+4,245.1% upside
Current
$0.88
$0.88
Target
$38.05
$38.05
$26.78
$38.05 avg
$46.02
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 12.33M | 11.14M | 10.37M |
| Net Income | -3,474,981 | -2,537,744 | -2,319,778 |
| Profit Margin | -28.2% | -22.8% | -22.4% |
| EBITDA | -5,324,397 | -5,017,327 | -4,875,631 |
| Free Cash Flow | -1,460,004 | -1,340,766 | -1,751,994 |
| Rev Growth | +17.2% | +1.6% | +25.0% |
| Debt/Equity | 0.34 | 0.29 | 0.35 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |